A federal judge has denied a motion to settle a lawsuit between Stryker and Biomet that alleges Biomet tried to erode Stryker’s customer base and take business from the medical device manufacturer. The scheme was allegedly organized by two former Stryker employees.
Stryker faces multiple lawsuits alleging that its Rejuvenate and ABG II metal-on-metal hip replacements caused severe injuries. In 2012, Stryker issued a Rejuvenate recall for the hip implants after studies found that the devices were much more likely to fail and require revision surgery than other devices.
The Rejuvenate and ABG II contain metal neck and stem components which can grind together and lead to tissue damage and toxic levels of metal in the bloodstream. Patients who received a defective Stryker hip replacement have filed hip replacement lawsuits alleging that the company released a dangerous device that caused injuries.